Decision Support · Side-by-side
Compare pricing, strengths, and use cases so it is easier to pick the right fit.
Change tools
Owkin
Best overallNeither BERG (BPGbio) nor Owkin is for everyday users — both are enterprise-grade platforms for drug discovery and medical research. BERG wins if you need causal AI to find novel drug targets from multi-omics data; Owkin wins if you need privacy-preserving AI on medical images and clinical records. The single biggest difference is that BERG focuses on causal modeling with a proprietary biobank, while Owkin specializes in federated learning across hospital networks.
BERG (BPGbio)
Owkin
Scores at a glance
Choose BERG (BPGbio) if
Choose Owkin if
Key differences
Facts side by side
| BERG (BPGbio) | Owkin | |
|---|---|---|
| Free plan | ||
| Mobile app | ||
| API access |
Common questions
Yes, BERG is specifically built for causal target discovery using multi-omics data, while Owkin is better for analyzing medical images and clinical trial data. If your goal is novel target identification, BERG is the stronger choice.
No. Owkin is an enterprise platform that requires integration with hospital IT systems. There is no mobile app or individual subscription.
Neither publishes pricing. Both require custom enterprise contracts likely costing hundreds of thousands to millions of dollars per year.
Neither is easy. Both have long onboarding cycles (months) involving data standardization, legal agreements, and technical setup. Owkin may be slightly faster if you already have standardized medical data.
BERG and Owkin are powerful but inaccessible to everyday users — both require enterprise partnerships, months of setup, and budgets most people don't have.
If you're a non-technical person or small team, neither BERG nor Owkin is for you — they are enterprise tools for large pharma and hospital networks. For everyday AI needs, look at simpler tools like ChatGPT, Claude, or specialized medical AI apps instead.
Detail pages: BERG (BPGbio) · Owkin
